Form 8-K - Current report:
SEC Accession No. 0001213900-26-037476
Filing Date
2026-03-31
Accepted
2026-03-31 16:20:28
Documents
14
Period of Report
2026-03-31
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT ea0283924-8k_ostherapies.htm   iXBRL 8-K 27944
2 OPINION OF OLSHAN FROME WOLOSKY LLP ea028392401ex5-1.htm EX-5.1 14046
3 GRAPHIC ea028392401_ex5-1img1.jpg GRAPHIC 9310
4 GRAPHIC ea028392401_ex5-1img2.jpg GRAPHIC 6091
  Complete submission text file 0001213900-26-037476.txt   234798

Data Files

Seq Description Document Type Size
5 XBRL SCHEMA FILE ostx-20260331.xsd EX-101.SCH 3023
6 XBRL LABEL FILE ostx-20260331_lab.xml EX-101.LAB 34239
7 XBRL PRESENTATION FILE ostx-20260331_pre.xml EX-101.PRE 22364
17 EXTRACTED XBRL INSTANCE DOCUMENT ea0283924-8k_ostherapies_htm.xml XML 3339
Mailing Address 15825 SHADY GROVE ROAD SUITE 135 ROCKVILLE MD 20850
Business Address 15825 SHADY GROVE ROAD SUITE 135 ROCKVILLE MD 20850 410-297-7793
OS Therapies Inc (Filer) CIK: 0001795091 (see all company filings)

EIN.: 825118368 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-42195 | Film No.: 26822220
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)